[3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
[3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
复制标题
[3H]spiroxatrine 标记大鼠海马中的 5-羟色胺 1A 样位点。
DOI:
10.1016/0024-3205(87)90723-5
复制
发表时间:
1987
期刊:
影响因子:
6.1
通讯作者:
Yamamura,HI
中科院分区:
文献类型:
--
作者:
Nelson,DL;Monroe,PJ;Lambert,G;Yamamura,HI
[3H]Spiroxatrine was examined as a potential ligand for the labeling of 5-HT1Asites in the rat hippocampus. Analysis of the binding of [3H]spiroxatrine in the absence and presence of varying concentrations of three monoamine neurotransmitters revealed that serotonin (5-HT) had high affinity (IC50= 20.7 nM for the [3H]spiroxatrine binding sites, consistent with the labeling of 5-HT1sites, while dopamine and norepinephrine had very low affinity (IC50=57600 nM and >10−4M respectively). Saturation studies of the binding of [3H]spiroxatrine revealed a single population of sites with a Kd=2.21 nM. Further pharmacologic characterization with the 5-HT1Aligands 8-hydroxy-2-(di-n-propylamino) tetralin, ipsapirone, and WB4101 and the butyrophenone compounds spiperone and haloperidol gave results that were consistent with [3H]spiroxatrine labeling 5-HT1Asites. This ligand produced stable, reproducible binding with a good ratio of specific to nonspecific binding. The binding of [3H]spiroxatrine was sensitive to GTP, suggesting that this ligand may act as an agonist. This was supported by the finding that spiroxatrine inhibits forskolin-stimulated adenylate cyclase activity (a proposed 5-HT1Areceptor model) in the rat hippocampus. Since [3H]spiroxatrine is structurally distinct from other currently available radioligands for the 5-HT1Asite, it should provide new information about the properties of this putative serotonergic receptor.